Strikingly, patients with severe asthma are marked by low levels of both NRF2 and HDAC2 mRNA levels in peripheral blood mononuclear cells, reinforcing the interpretation that the decrease in the expression of these genes is a pivotal determinant of susceptibility to asthma exacerbations [48]. The gene discussed is HDAC2; the disease is asthma.